Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 29 studies | 26% ± 10% | |
mast cell | 23 studies | 36% ± 15% | |
naive B cell | 19 studies | 26% ± 9% | |
memory B cell | 15 studies | 23% ± 6% | |
non-classical monocyte | 11 studies | 30% ± 12% | |
macrophage | 8 studies | 21% ± 6% | |
classical monocyte | 7 studies | 23% ± 10% | |
monocyte | 7 studies | 19% ± 4% | |
plasmacytoid dendritic cell | 7 studies | 24% ± 7% | |
precursor B cell | 6 studies | 35% ± 9% | |
conventional dendritic cell | 4 studies | 36% ± 16% | |
immature B cell | 4 studies | 37% ± 10% | |
plasma cell | 3 studies | 28% ± 15% | |
myeloid cell | 3 studies | 26% ± 4% | |
pro-B cell | 3 studies | 29% ± 8% | |
germinal center B cell | 3 studies | 26% ± 4% | |
megakaryocyte | 3 studies | 42% ± 12% | |
platelet | 3 studies | 20% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 25% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1626.08 | 578 / 578 | 87% | 7.91 | 1001 / 1155 |
breast | 90% | 334.22 | 412 / 459 | 94% | 7.64 | 1048 / 1118 |
bladder | 100% | 385.38 | 21 / 21 | 51% | 3.63 | 258 / 504 |
stomach | 87% | 257.97 | 311 / 359 | 63% | 4.06 | 179 / 286 |
skin | 66% | 202.50 | 1185 / 1809 | 80% | 8.31 | 377 / 472 |
intestine | 92% | 732.19 | 886 / 966 | 51% | 3.40 | 271 / 527 |
brain | 38% | 126.38 | 999 / 2642 | 91% | 8.31 | 643 / 705 |
uterus | 69% | 165.35 | 117 / 170 | 59% | 2.95 | 272 / 459 |
kidney | 42% | 155.12 | 37 / 89 | 84% | 6.85 | 756 / 901 |
prostate | 81% | 274.90 | 198 / 245 | 44% | 1.66 | 221 / 502 |
esophagus | 81% | 278.72 | 1172 / 1445 | 44% | 2.05 | 80 / 183 |
thymus | 40% | 167.48 | 261 / 653 | 69% | 4.33 | 417 / 605 |
adrenal gland | 83% | 258.16 | 214 / 258 | 22% | 0.83 | 50 / 230 |
pancreas | 20% | 47.63 | 65 / 328 | 82% | 7.48 | 146 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 121.39 | 29 / 29 |
peripheral blood | 100% | 5304.39 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 4944.54 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 621.45 | 1179 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 7.24 | 37 / 45 |
ovary | 22% | 47.02 | 39 / 180 | 57% | 2.61 | 246 / 430 |
blood vessel | 67% | 255.82 | 889 / 1335 | 0% | 0 | 0 / 0 |
liver | 34% | 76.20 | 77 / 226 | 30% | 1.63 | 123 / 406 |
heart | 34% | 81.22 | 289 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 1.13 | 22 / 80 |
muscle | 3% | 6.11 | 28 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001780 | Biological process | neutrophil homeostasis |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0007498 | Biological process | mesoderm development |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0030167 | Biological process | proteoglycan catabolic process |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0061516 | Biological process | monocyte proliferation |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0098761 | Biological process | cellular response to interleukin-7 |
GO_1990959 | Biological process | eosinophil homeostasis |
GO_0045087 | Biological process | innate immune response |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0002553 | Biological process | histamine secretion by mast cell |
GO_0038095 | Biological process | Fc-epsilon receptor signaling pathway |
GO_0002902 | Biological process | regulation of B cell apoptotic process |
GO_0001805 | Biological process | positive regulation of type III hypersensitivity |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0045579 | Biological process | positive regulation of B cell differentiation |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0002344 | Biological process | B cell affinity maturation |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0002250 | Biological process | adaptive immune response |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0150153 | Biological process | positive regulation of interleukin-17A production |
GO_0042113 | Biological process | B cell activation |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0002721 | Biological process | regulation of B cell cytokine production |
GO_1901647 | Biological process | positive regulation of synoviocyte proliferation |
GO_0071226 | Biological process | cellular response to molecule of fungal origin |
GO_0006468 | Biological process | protein phosphorylation |
GO_0001812 | Biological process | positive regulation of type I hypersensitivity |
GO_0048469 | Biological process | cell maturation |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0030889 | Biological process | negative regulation of B cell proliferation |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0016004 | Molecular function | phospholipase activator activity |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0043274 | Molecular function | phospholipase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BTK |
Protein name | Tyrosine-protein kinase BTK isoform 51 Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 9 Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 5 Tyrosine-protein kinase BTK isoform 65 Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 7 Tyrosine-protein kinase BTK isoform (Lacking exon 15 to 18) Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) non-specific protein-tyrosine kinase (EC 2.7.10.2) Bruton tyrosine kinase Tyrosine-protein kinase BTK isoform (Lacking exon 14) Bruton tyrosine kinase (Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 8) Tyrosine-protein kinase BTK isoform (Lacking exon 13 to 17) Bruton tyrosine kinase (Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 4) Bruton tyrosine kinase (Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 10) Tyrosine-protein kinase BTK isoform 52 Bruton tyrosine kinase (Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 1) Dominant-negative kinase-deficient Brutons tyrosine kinase isoform 6 Tyrosine-protein kinase (EC 2.7.10.2) |
Synonyms | isoform 9 4 hCG_20400 ATK BPK deficient 3 2 6 5 1 8 kinase AGMX1 7 |
Description | FUNCTION: Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling . Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation . After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members . PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK . BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways . Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway . The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense . Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells . Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation . BTK also plays a critical role in transcription regulation . Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes . BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B . Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3 . Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR . GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression . ARID3A and NFAT are other transcriptional target of BTK . BTK is required for the formation of functional ARID3A DNA-binding complexes . There is however no evidence that BTK itself binds directly to DNA . BTK has a dual role in the regulation of apoptosis . . |
Accessions | Q3MS92 ENST00000695621.1 ENST00000695629.1 Q3MS95 ENST00000695628.1 ENST00000695626.1 ENST00000695625.1 A0A8Q3WKS7 ENST00000470329.1 ENST00000695643.1 Q3MS88 ENST00000695617.1 ENST00000695631.1 Q3MS94 Q3MS97 ENST00000695616.1 Q3MS96 Q3MS93 ENST00000695627.1 A0A8Q3WKR7 ENST00000695623.1 ENST00000695618.1 A0A8Q3SI44 Q572P1 Q572P2 A0A8Q3SHX9 ENST00000703407.1 Q3MS91 ENST00000621635.4 [Q06187-2] ENST00000695630.1 Q572P5 A0A8Q3WKM0 ENST00000695614.1 [Q06187-1] ENST00000695622.1 Q5JY90 A0A8Q3WLR2 Q3MS89 Q3MS90 U3NG26 A0A8Q3WLZ5 A0A8Q3WL62 ENST00000695615.1 [Q06187-1] A0A8Q3WKN1 A0A8Q3SI38 A0A8Q3SI35 Q572P4 A0A8Q3SHZ6 Q572P3 ENST00000695619.1 ENST00000308731.8 [Q06187-1] ENST00000695620.1 Q572P0 Q06187 |